Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-28 Purchase |
2025-03-03 4:45 pm |
PDS Biotechnology Corp | PDSB | Glover Stephen C. Director |
15,061 | $1.66 | $25,001 | 93,912 (Direct) |
View |
| 2021-06-15 Purchase |
2021-06-17 7:15 pm |
PDS Biotechnology Corp | PDSB | Glover Steve C Director |
5,882 | $8.5 | $49,997 | 72,790 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer |
1,627 | $0 | 1,627 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-25 4:05 pm |
N/A 2034-06-24 |
PDS Biotechnology Corp | PDSB | Glover Stephen C. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-17 5:26 pm |
N/A 2033-07-14 |
PDS Biotechnology Corp | PDSB | Glover Stephen C. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:17 pm |
N/A 2033-06-07 |
Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director |
142,500 | $0 | 142,500 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-26 8:20 pm |
N/A 2033-05-18 |
Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director |
210,000 | $0 | 210,000 (Direct) |
View |
| 2022-12-12 Option Award |
2022-12-14 7:24 pm |
2022-12-12 N/A |
ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer |
1,499,542 | $0 | 1,366,196 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-29 4:16 pm |
N/A 2032-06-28 |
PDS Biotechnology Corp | PDSB | Glover Steve C Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 7:15 pm |
N/A 2031-06-17 |
PDS Biotechnology Corp | PDSB | Glover Steve C Director |
9,000 | $0 | 72,790 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-25 6:57 pm |
N/A 2030-06-23 |
PDS Biotechnology Corp | PDSB | Glover Steve C Director |
9,000 | $0 | 9,000 (Direct) |
View |